{"gene":"TOX2","run_date":"2026-06-10T10:51:55","timeline":{"discoveries":[{"year":2019,"finding":"TOX2 cooperates with TOX and NR4A transcription factors downstream of NFAT (in the absence of AP-1) to drive the transcriptional program of CD8+ T cell exhaustion; Tox/Tox2 double-knockout CAR TILs showed increased cytokine expression, decreased inhibitory receptor expression, and increased chromatin accessibility at NFκB/bZIP motif-enriched regions; positive regulatory loops between TOX and NR4A were identified.","method":"CAR T cell mouse model, CRISPR double-knockout (Tox DKO), ATAC-seq, transcriptional analysis, genetic epistasis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic KO with defined cellular and transcriptional phenotype, ATAC-seq chromatin data, replicated across multiple KO conditions","pmids":["31152140"],"is_preprint":false},{"year":2019,"finding":"TOX2 is required for T follicular helper (Tfh) cell differentiation: ectopic expression of Tox2 was sufficient to drive Bcl6 expression and Tfh development; Tox2 ChIP-seq showed direct binding to Bcl6 and other Tfh-associated loci; Tox2 binding was associated with increased chromatin accessibility (ATAC-seq); Tox2-/- mice had defective Tfh differentiation, and combined Tox2/Tox deficiency abolished Tfh differentiation, establishing a Tox2-Bcl6 feed-forward loop.","method":"Tox2-/- mouse model, ectopic expression, genome-wide ChIP-seq, ATAC-seq, epistasis with Tox","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal gain- and loss-of-function experiments, genome-wide ChIP-seq showing direct Bcl6 binding, ATAC-seq, KO mouse phenotype","pmids":["31732165"],"is_preprint":false},{"year":2014,"finding":"TOX2 controls human NK cell development by directly upregulating transcription of TBX21 (T-BET), acting upstream of TBX21; TOX2 knockdown hindered early NK cell developmental transitions, and overexpression of T-BET rescued TOX2 knockdown phenotypes; TOX2 acted independently of ETS-1.","method":"shRNA gene silencing, overexpression in CD34+ cord blood cells, rescue experiment with T-BET overexpression, in vitro NK cell differentiation assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — loss-of-function, gain-of-function, rescue epistasis experiment, two orthogonal methods in single lab","pmids":["25352127"],"is_preprint":false},{"year":2021,"finding":"Tox2 is required for maintenance of germinal center (GC) TFH cells and generation of memory TFH cells; Tox2 overexpression maintained TFH-associated gene expression and inhibited spontaneous conversion of GC TFH cells into TH1-like cells; Tox2-deficient mice showed impaired secondary TFH expansion upon reimmunization.","method":"Tox2-/- mouse model, Tox2 overexpression in human GC TFH cells, reimmunization/secondary infection challenge, transcriptional analysis","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Moderate — KO mouse model with defined phenotype, human cell overexpression with transcriptional readout, two orthogonal experimental systems","pmids":["34623911"],"is_preprint":false},{"year":2023,"finding":"TOX2 mediates oncogenesis in Natural Killer/T-cell lymphoma (NKTL) downstream of RUNX3, which regulates TOX2 transcription by binding to active elements of its super-enhancer; TOX2 knockdown or CRISPR-dCas9 interference of its super-enhancer impaired cell proliferation, survival, and colony formation in vitro and tumor formation in vivo; PRL-3 (metastasis-associated phosphatase) was identified and validated as a key downstream effector of TOX2.","method":"shRNA knockdown, CRISPR-dCas9 SE interference, luciferase reporter assay, ChIP-PCR, in vivo xenograft model","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional experiments (KD, CRISPR, reporter, in vivo), single lab","pmids":["37032358"],"is_preprint":false},{"year":2023,"finding":"In human CAR T cells, TOX2 (in contrast to TOX) promotes central memory T cell (TCM) differentiation: TOX2 knockdown decreased TCM percentage and reduced proliferation; TOX2 bound to promoters of numerous TCM-associated genes; increased TET2 loss led to increased TOX2 expression and chromatin accessibility at TOX2 locus.","method":"TOX2 knockdown, ChIP-seq (TOX2 at TCM gene promoters), ATAC-seq, flow cytometry, gene expression analysis in human CAR T cells","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq demonstrating direct promoter binding, loss-of-function with cellular phenotype, single lab","pmids":["37467321"],"is_preprint":false},{"year":2024,"finding":"Tox2 is required for metabolic adaptation and tissue residency of gut ILC3: Tox2 deficiency decreased ILC3 specifically in gut (not central sites) and impaired control of Citrobacter rodentium infection; single-cell transcriptomics revealed decreased Hexokinase-2 expression in Tox2-deficient ILC3; Tox2-/- ILC3 showed decreased glycolytic capacity for protein translation; ectopic Hexokinase-2 expression rescued Tox2-/- ILC3 defects; hypoxia and IL-17A each induced Tox2 expression in ILC3.","method":"Tox2-/- mouse model, single-cell transcriptional profiling, ectopic Hexokinase-2 rescue, infection challenge, glycolysis assay","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mouse, rescue experiment establishing Hexokinase-2 as downstream mediator, single-cell transcriptomics, infection phenotype, multiple orthogonal methods","pmids":["38677292"],"is_preprint":false},{"year":2024,"finding":"TOX2 nuclear-cytosol translocation is regulated by deacetylation cooperatively mediated by Sirt1 and kinase TBK1; nuclear TOX and TOX2 form a protein complex and repress HAVCR2 (TIM3) promoter activity by recruiting corepressor LCOR and deacetylase HDAC3; radiation damage induced TOX2 nuclear translocation and decreased Sirt1, TIM3, and caspase 1 expression; knockdown of TOX2, TOX, or LCOR, or HDAC3 inhibition induced leukemic cell apoptosis in vitro and reduced tumor growth in vivo.","method":"Co-immunoprecipitation (protein complex), subcellular fractionation/localization, luciferase promoter assay, shRNA knockdown, HDAC3 inhibitor, in vivo xenograft model","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for complex, promoter reporter assay, deacetylation-dependent localization, in vivo functional data, single lab","pmids":["39080376"],"is_preprint":false},{"year":2025,"finding":"Genome-wide binding sites of TOX2 in primary human CD8 T cells were mapped using the Calling Cards transposon-based method; TOX2 binding sites in CD8 T cells were identified and associated with exhaustion and memory gene programs.","method":"Calling Cards transposon-based TF mapping (chromatin binding), integration with multi-omic sequencing in primary human CD8 T cells","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — genome-wide binding map in primary cells, single preprint, no functional validation of individual binding events","pmids":["bio_10.1101_2025.10.09.681414"],"is_preprint":true}],"current_model":"TOX2 is an HMG-box transcription factor that directly binds target gene loci to regulate lymphocyte differentiation and function: it drives T follicular helper cell differentiation via a Tox2-Bcl6 feed-forward loop, promotes central memory CD8 T cell identity by binding TCM gene promoters, cooperates with TOX and NR4A downstream of NFAT to enforce CD8 T cell exhaustion, controls NK cell development by directly upregulating TBX21 transcription, supports gut ILC3 tissue residency through regulation of Hexokinase-2-dependent glycolysis, and undergoes Sirt1/TBK1-regulated nuclear-cytosol translocation that determines whether it forms a repressive complex with TOX/LCOR/HDAC3 to suppress TIM3 transcription or acts as an activator, with aberrant super-enhancer-driven overexpression promoting oncogenesis in NK/T cell lymphoma via a RUNX3-TOX2-PRL-3 pathway."},"narrative":{"mechanistic_narrative":"TOX2 is an HMG-box transcription factor that directly binds target gene loci to program the differentiation and function of multiple lymphocyte lineages [PMID:31732165, PMID:25352127]. In CD4 T cells it is both necessary and sufficient for T follicular helper (Tfh) differentiation, where ectopic expression drives Bcl6 induction and genome-wide ChIP-seq places TOX2 directly on the Bcl6 locus, establishing a Tox2-Bcl6 feed-forward loop and sustaining germinal-center and memory Tfh identity [PMID:31732165, PMID:34623911]. In CD8 T cells TOX2 cooperates with TOX and NR4A factors downstream of NFAT to enforce the exhaustion transcriptional program, while in human CAR T cells it instead binds central-memory gene promoters to promote TCM differentiation [PMID:31152140, PMID:37467321]. TOX2 also acts upstream in innate lymphocytes, directly upregulating TBX21 (T-BET) transcription to drive human NK cell development and supporting gut ILC3 tissue residency by maintaining Hexokinase-2-dependent glycolysis [PMID:25352127, PMID:38677292]. Its activity is gated by Sirt1/TBK1-controlled nuclear-cytosol translocation: nuclear TOX2 forms a complex with TOX, LCOR, and HDAC3 to repress the HAVCR2 (TIM3) promoter [PMID:39080376]. In NK/T-cell lymphoma, super-enhancer-driven TOX2 overexpression downstream of RUNX3 promotes oncogenesis through the downstream effector PRL-3 [PMID:37032358].","teleology":[{"year":2014,"claim":"Established that TOX2 functions in innate lymphocyte development by acting as a direct upstream activator of the master NK transcription factor T-BET, defining its first molecular target.","evidence":"shRNA silencing, overexpression, and T-BET rescue epistasis in CD34+ cord blood NK differentiation","pmids":["25352127"],"confidence":"High","gaps":["Direct binding to the TBX21 locus not demonstrated by ChIP","ETS-1 independence shown but other cofactors not mapped"]},{"year":2019,"claim":"Defined TOX2 as a driver of CD8 T cell exhaustion acting combinatorially with TOX and NR4A downstream of NFAT, revealing redundancy within the TOX family in dysfunctional T cells.","evidence":"CAR T mouse model, Tox/Tox2 CRISPR double-knockout, ATAC-seq and transcriptional analysis","pmids":["31152140"],"confidence":"High","gaps":["Direct TOX2 target loci in exhaustion not separated from TOX","Mechanism of cooperation with NR4A not biochemically resolved"]},{"year":2019,"claim":"Showed TOX2 is necessary and sufficient for Tfh differentiation through direct genomic binding to Bcl6, identifying the Tox2-Bcl6 feed-forward loop as its core CD4 T cell circuit.","evidence":"Tox2-/- mouse, ectopic expression, genome-wide ChIP-seq and ATAC-seq, epistasis with Tox","pmids":["31732165"],"confidence":"High","gaps":["Cofactors recruited to TOX2-bound Tfh loci not identified","Relationship to TCM/exhaustion programs in CD8 not addressed"]},{"year":2021,"claim":"Extended the Tfh role to maintenance, showing TOX2 preserves germinal-center Tfh identity and enables memory Tfh generation rather than just initiating differentiation.","evidence":"Tox2-/- mouse, overexpression in human GC Tfh cells, reimmunization challenge","pmids":["34623911"],"confidence":"High","gaps":["Direct targets enforcing maintenance versus Th1 conversion not mapped","Memory Tfh persistence mechanism unresolved"]},{"year":2023,"claim":"Distinguished TOX2 from TOX functionally, demonstrating TOX2 binds TCM gene promoters to promote central-memory differentiation in human CAR T cells, and linked TET2 loss to elevated TOX2.","evidence":"TOX2 knockdown, ChIP-seq, ATAC-seq, flow cytometry in human CAR T cells","pmids":["37467321"],"confidence":"Medium","gaps":["Single lab, no in vivo validation","Mechanism reconciling memory-promoting versus exhaustion roles unresolved"]},{"year":2023,"claim":"Identified TOX2 as an oncogenic node in NK/T-cell lymphoma driven by RUNX3 via super-enhancer activation, with PRL-3 as a downstream effector.","evidence":"shRNA knockdown, CRISPR-dCas9 super-enhancer interference, luciferase reporter, ChIP-PCR, xenograft","pmids":["37032358"],"confidence":"Medium","gaps":["Direct TOX2 binding to the PRL-3 locus not shown","Single lab"]},{"year":2024,"claim":"Revealed a metabolic function for TOX2 in maintaining gut ILC3 tissue residency through Hexokinase-2-dependent glycolysis, extending its role beyond transcriptional lineage specification.","evidence":"Tox2-/- mouse, single-cell transcriptomics, ectopic Hexokinase-2 rescue, Citrobacter infection and glycolysis assays","pmids":["38677292"],"confidence":"High","gaps":["Direct binding to the Hexokinase-2 locus not demonstrated","Upstream hypoxia/IL-17A signaling to TOX2 not mechanistically mapped"]},{"year":2024,"claim":"Uncovered post-translational control of TOX2 via Sirt1/TBK1-regulated deacetylation and translocation, and a TOX2-TOX-LCOR-HDAC3 repressive complex acting on the TIM3 promoter.","evidence":"Co-IP, subcellular fractionation, luciferase promoter assay, shRNA, HDAC3 inhibition, xenograft in leukemic cells","pmids":["39080376"],"confidence":"Medium","gaps":["Single Co-IP-based complex without reciprocal structural validation","Acetylation sites on TOX2 not mapped"]},{"year":2025,"claim":"Provided a genome-wide binding map of TOX2 in primary human CD8 T cells, linking its occupancy to exhaustion and memory gene programs.","evidence":"Calling Cards transposon-based TF mapping integrated with multi-omics in primary human CD8 T cells (preprint)","pmids":["bio_10.1101_2025.10.09.681414"],"confidence":"Medium","gaps":["Single preprint, no functional validation of individual binding events","Direct versus indirect targets not resolved"]},{"year":null,"claim":"How TOX2 selects between activating (memory, Tfh, T-BET) and repressive (TIM3, exhaustion) transcriptional outputs across lineages, and which cofactors dictate this switch, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified cofactor logic explaining context-dependent activator versus repressor roles","Structural basis of HMG-box target selection not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,2,5]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,5,8]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,7]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[7]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,2,5]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,1,2,6]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4]}],"complexes":["TOX2-TOX-LCOR-HDAC3 repressive complex"],"partners":["TOX","LCOR","HDAC3","NR4A","SIRT1","TBK1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96NM4","full_name":"TOX high mobility group box family member 2","aliases":["Granulosa cell HMG box protein 1","GCX-1"],"length_aa":488,"mass_kda":51.6,"function":"Putative transcriptional activator involved in the hypothalamo-pituitary-gonadal system","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q96NM4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TOX2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TOX2","total_profiled":1310},"omim":[{"mim_id":"611163","title":"TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 2; TOX2","url":"https://www.omim.org/entry/611163"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":46.7}],"url":"https://www.proteinatlas.org/search/TOX2"},"hgnc":{"alias_symbol":["dJ1108D11.2","GCX-1"],"prev_symbol":["C20orf100"]},"alphafold":{"accession":"Q96NM4","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96NM4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96NM4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96NM4-F1-predicted_aligned_error_v6.png","plddt_mean":51.47},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TOX2","jax_strain_url":"https://www.jax.org/strain/search?query=TOX2"},"sequence":{"accession":"Q96NM4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96NM4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96NM4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96NM4"}},"corpus_meta":[{"pmid":"31152140","id":"PMC_31152140","title":"TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31152140","citation_count":634,"is_preprint":false},{"pmid":"31732165","id":"PMC_31732165","title":"The Transcription Factor Tox2 Drives T Follicular Helper Cell Development via Regulating Chromatin Accessibility.","date":"2019","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/31732165","citation_count":136,"is_preprint":false},{"pmid":"8672886","id":"PMC_8672886","title":"Chromosomal organization of TOX2, a complex locus controlling host-selective toxin biosynthesis in Cochliobolus carbonum.","date":"1996","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/8672886","citation_count":70,"is_preprint":false},{"pmid":"25352127","id":"PMC_25352127","title":"TOX2 regulates human natural killer cell development by controlling T-BET expression.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25352127","citation_count":65,"is_preprint":false},{"pmid":"34623911","id":"PMC_34623911","title":"Tox2 is required for the maintenance of GC TFH cells and the generation of memory TFH cells.","date":"2021","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/34623911","citation_count":34,"is_preprint":false},{"pmid":"35111387","id":"PMC_35111387","title":"CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma.","date":"2022","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/35111387","citation_count":31,"is_preprint":false},{"pmid":"37032358","id":"PMC_37032358","title":"Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma.","date":"2023","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37032358","citation_count":27,"is_preprint":false},{"pmid":"28153336","id":"PMC_28153336","title":"Genome-wide Regional Heritability Mapping Identifies a Locus Within the TOX2 Gene Associated With Major Depressive Disorder.","date":"2016","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/28153336","citation_count":24,"is_preprint":false},{"pmid":"11860263","id":"PMC_11860263","title":"An extended physical map of the TOX2 locus of Cochliobolus carbonum required for biosynthesis of HC-toxin.","date":"2002","source":"Fungal genetics and biology : FG & B","url":"https://pubmed.ncbi.nlm.nih.gov/11860263","citation_count":24,"is_preprint":false},{"pmid":"37467321","id":"PMC_37467321","title":"TOX2 coordinates with TET2 to positively regulate central memory differentiation in human CAR T cells.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/37467321","citation_count":23,"is_preprint":false},{"pmid":"8918240","id":"PMC_8918240","title":"Transposon-like sequences at the TOX2 locus of the plant-pathogenic fungus Cochliobolus carbonum.","date":"1996","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8918240","citation_count":20,"is_preprint":false},{"pmid":"10656588","id":"PMC_10656588","title":"Reduced virulence caused by meiotic instability of the TOX2 chromosome of the maize pathogen Cochliobolus carbonum.","date":"2000","source":"Molecular plant-microbe interactions : MPMI","url":"https://pubmed.ncbi.nlm.nih.gov/10656588","citation_count":18,"is_preprint":false},{"pmid":"38677292","id":"PMC_38677292","title":"Transcription factor Tox2 is required for metabolic adaptation and tissue residency of ILC3 in the gut.","date":"2024","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/38677292","citation_count":16,"is_preprint":false},{"pmid":"37011499","id":"PMC_37011499","title":"Geniposide prevents tumor growth by inhibiting colonic interleukin-1β and monocyte chemoattractant protein-1 via down-regulated expression of cyclooxygenase-2 and thymocyte selection-associated high mobility box proteins TOX/TOX2 in azoxymethane/dextran sulfate sodium-treated mice.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37011499","citation_count":10,"is_preprint":false},{"pmid":"35378414","id":"PMC_35378414","title":"Two hydroxyflavanones isolated from Scutellaria baicalensis roots prevent colitis-associated colon cancer in C57BL/6 J mice by inhibiting programmed cell death-1, interleukin 10, and thymocyte selection-associated high mobility group box proteins TOX/TOX2.","date":"2022","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35378414","citation_count":8,"is_preprint":false},{"pmid":"16535561","id":"PMC_16535561","title":"Polymorphic Chromosomes Bearing the Tox2 Locus in Cochliobolus carbonum Behave as Homologs during Meiosis.","date":"1997","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/16535561","citation_count":6,"is_preprint":false},{"pmid":"39080376","id":"PMC_39080376","title":"TOX2 nuclear-cytosol translocation is linked to leukemogenesis of acute T-cell leukemia by repressing TIM3 transcription.","date":"2024","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/39080376","citation_count":5,"is_preprint":false},{"pmid":"39766129","id":"PMC_39766129","title":"Ulcerative Colitis, LAIR1 and TOX2 Expression, and Colorectal Cancer Deep Learning Image Classification Using Convolutional Neural Networks.","date":"2024","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/39766129","citation_count":3,"is_preprint":false},{"pmid":"36990263","id":"PMC_36990263","title":"Acertannin prevents azoxymethane/dextran sulfate sodium-induced colon cancer growth by inhibiting the colonic expression of interleukin-1β, monocyte chemoattractant protein-1, cyclooxygenase-2, and thymocyte selection-associated high mobility group box proteins (TOX)/TOX2 in C57BL/6J mice.","date":"2023","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36990263","citation_count":3,"is_preprint":false},{"pmid":"41020836","id":"PMC_41020836","title":"The TOX2 Gene Is Responsible for Conidiation and Full Virulence in Fusarium pseudograminearum.","date":"2025","source":"Current issues in molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/41020836","citation_count":0,"is_preprint":false},{"pmid":"8604230","id":"PMC_8604230","title":"[Genetic analysis of Vibrio cholerae chromosomal regions containing the tox-2 mutation, affecting production of cholera toxin].","date":"1995","source":"Molekuliarnaia genetika, mikrobiologiia i virusologiia","url":"https://pubmed.ncbi.nlm.nih.gov/8604230","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.09.681414","title":"Scalable transcription factor mapping uncovers the regulatory dynamics of natural and synthetic transcription factors in human T cell states","date":"2025-10-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.09.681414","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.10.10.681694","title":"Obesity Impairs the Antitumor Activity of CAR-T Cells in Triple-Negative Breast Cancer","date":"2025-10-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.10.681694","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14546,"output_tokens":2671,"usd":0.041851,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9898,"output_tokens":3195,"usd":0.064683,"stage2_stop_reason":"end_turn"},"total_usd":0.106534,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX2 cooperates with TOX and NR4A transcription factors downstream of NFAT (in the absence of AP-1) to drive the transcriptional program of CD8+ T cell exhaustion; Tox/Tox2 double-knockout CAR TILs showed increased cytokine expression, decreased inhibitory receptor expression, and increased chromatin accessibility at NFκB/bZIP motif-enriched regions; positive regulatory loops between TOX and NR4A were identified.\",\n      \"method\": \"CAR T cell mouse model, CRISPR double-knockout (Tox DKO), ATAC-seq, transcriptional analysis, genetic epistasis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic KO with defined cellular and transcriptional phenotype, ATAC-seq chromatin data, replicated across multiple KO conditions\",\n      \"pmids\": [\"31152140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX2 is required for T follicular helper (Tfh) cell differentiation: ectopic expression of Tox2 was sufficient to drive Bcl6 expression and Tfh development; Tox2 ChIP-seq showed direct binding to Bcl6 and other Tfh-associated loci; Tox2 binding was associated with increased chromatin accessibility (ATAC-seq); Tox2-/- mice had defective Tfh differentiation, and combined Tox2/Tox deficiency abolished Tfh differentiation, establishing a Tox2-Bcl6 feed-forward loop.\",\n      \"method\": \"Tox2-/- mouse model, ectopic expression, genome-wide ChIP-seq, ATAC-seq, epistasis with Tox\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal gain- and loss-of-function experiments, genome-wide ChIP-seq showing direct Bcl6 binding, ATAC-seq, KO mouse phenotype\",\n      \"pmids\": [\"31732165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TOX2 controls human NK cell development by directly upregulating transcription of TBX21 (T-BET), acting upstream of TBX21; TOX2 knockdown hindered early NK cell developmental transitions, and overexpression of T-BET rescued TOX2 knockdown phenotypes; TOX2 acted independently of ETS-1.\",\n      \"method\": \"shRNA gene silencing, overexpression in CD34+ cord blood cells, rescue experiment with T-BET overexpression, in vitro NK cell differentiation assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function, gain-of-function, rescue epistasis experiment, two orthogonal methods in single lab\",\n      \"pmids\": [\"25352127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Tox2 is required for maintenance of germinal center (GC) TFH cells and generation of memory TFH cells; Tox2 overexpression maintained TFH-associated gene expression and inhibited spontaneous conversion of GC TFH cells into TH1-like cells; Tox2-deficient mice showed impaired secondary TFH expansion upon reimmunization.\",\n      \"method\": \"Tox2-/- mouse model, Tox2 overexpression in human GC TFH cells, reimmunization/secondary infection challenge, transcriptional analysis\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse model with defined phenotype, human cell overexpression with transcriptional readout, two orthogonal experimental systems\",\n      \"pmids\": [\"34623911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TOX2 mediates oncogenesis in Natural Killer/T-cell lymphoma (NKTL) downstream of RUNX3, which regulates TOX2 transcription by binding to active elements of its super-enhancer; TOX2 knockdown or CRISPR-dCas9 interference of its super-enhancer impaired cell proliferation, survival, and colony formation in vitro and tumor formation in vivo; PRL-3 (metastasis-associated phosphatase) was identified and validated as a key downstream effector of TOX2.\",\n      \"method\": \"shRNA knockdown, CRISPR-dCas9 SE interference, luciferase reporter assay, ChIP-PCR, in vivo xenograft model\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional experiments (KD, CRISPR, reporter, in vivo), single lab\",\n      \"pmids\": [\"37032358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In human CAR T cells, TOX2 (in contrast to TOX) promotes central memory T cell (TCM) differentiation: TOX2 knockdown decreased TCM percentage and reduced proliferation; TOX2 bound to promoters of numerous TCM-associated genes; increased TET2 loss led to increased TOX2 expression and chromatin accessibility at TOX2 locus.\",\n      \"method\": \"TOX2 knockdown, ChIP-seq (TOX2 at TCM gene promoters), ATAC-seq, flow cytometry, gene expression analysis in human CAR T cells\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq demonstrating direct promoter binding, loss-of-function with cellular phenotype, single lab\",\n      \"pmids\": [\"37467321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Tox2 is required for metabolic adaptation and tissue residency of gut ILC3: Tox2 deficiency decreased ILC3 specifically in gut (not central sites) and impaired control of Citrobacter rodentium infection; single-cell transcriptomics revealed decreased Hexokinase-2 expression in Tox2-deficient ILC3; Tox2-/- ILC3 showed decreased glycolytic capacity for protein translation; ectopic Hexokinase-2 expression rescued Tox2-/- ILC3 defects; hypoxia and IL-17A each induced Tox2 expression in ILC3.\",\n      \"method\": \"Tox2-/- mouse model, single-cell transcriptional profiling, ectopic Hexokinase-2 rescue, infection challenge, glycolysis assay\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mouse, rescue experiment establishing Hexokinase-2 as downstream mediator, single-cell transcriptomics, infection phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"38677292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TOX2 nuclear-cytosol translocation is regulated by deacetylation cooperatively mediated by Sirt1 and kinase TBK1; nuclear TOX and TOX2 form a protein complex and repress HAVCR2 (TIM3) promoter activity by recruiting corepressor LCOR and deacetylase HDAC3; radiation damage induced TOX2 nuclear translocation and decreased Sirt1, TIM3, and caspase 1 expression; knockdown of TOX2, TOX, or LCOR, or HDAC3 inhibition induced leukemic cell apoptosis in vitro and reduced tumor growth in vivo.\",\n      \"method\": \"Co-immunoprecipitation (protein complex), subcellular fractionation/localization, luciferase promoter assay, shRNA knockdown, HDAC3 inhibitor, in vivo xenograft model\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for complex, promoter reporter assay, deacetylation-dependent localization, in vivo functional data, single lab\",\n      \"pmids\": [\"39080376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Genome-wide binding sites of TOX2 in primary human CD8 T cells were mapped using the Calling Cards transposon-based method; TOX2 binding sites in CD8 T cells were identified and associated with exhaustion and memory gene programs.\",\n      \"method\": \"Calling Cards transposon-based TF mapping (chromatin binding), integration with multi-omic sequencing in primary human CD8 T cells\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — genome-wide binding map in primary cells, single preprint, no functional validation of individual binding events\",\n      \"pmids\": [\"bio_10.1101_2025.10.09.681414\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"TOX2 is an HMG-box transcription factor that directly binds target gene loci to regulate lymphocyte differentiation and function: it drives T follicular helper cell differentiation via a Tox2-Bcl6 feed-forward loop, promotes central memory CD8 T cell identity by binding TCM gene promoters, cooperates with TOX and NR4A downstream of NFAT to enforce CD8 T cell exhaustion, controls NK cell development by directly upregulating TBX21 transcription, supports gut ILC3 tissue residency through regulation of Hexokinase-2-dependent glycolysis, and undergoes Sirt1/TBK1-regulated nuclear-cytosol translocation that determines whether it forms a repressive complex with TOX/LCOR/HDAC3 to suppress TIM3 transcription or acts as an activator, with aberrant super-enhancer-driven overexpression promoting oncogenesis in NK/T cell lymphoma via a RUNX3-TOX2-PRL-3 pathway.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TOX2 is an HMG-box transcription factor that directly binds target gene loci to program the differentiation and function of multiple lymphocyte lineages [#1, #2]. In CD4 T cells it is both necessary and sufficient for T follicular helper (Tfh) differentiation, where ectopic expression drives Bcl6 induction and genome-wide ChIP-seq places TOX2 directly on the Bcl6 locus, establishing a Tox2-Bcl6 feed-forward loop and sustaining germinal-center and memory Tfh identity [#1, #3]. In CD8 T cells TOX2 cooperates with TOX and NR4A factors downstream of NFAT to enforce the exhaustion transcriptional program, while in human CAR T cells it instead binds central-memory gene promoters to promote TCM differentiation [#0, #5]. TOX2 also acts upstream in innate lymphocytes, directly upregulating TBX21 (T-BET) transcription to drive human NK cell development and supporting gut ILC3 tissue residency by maintaining Hexokinase-2-dependent glycolysis [#2, #6]. Its activity is gated by Sirt1/TBK1-controlled nuclear-cytosol translocation: nuclear TOX2 forms a complex with TOX, LCOR, and HDAC3 to repress the HAVCR2 (TIM3) promoter [#7]. In NK/T-cell lymphoma, super-enhancer-driven TOX2 overexpression downstream of RUNX3 promotes oncogenesis through the downstream effector PRL-3 [#4].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 2014,\n      \"claim\": \"Established that TOX2 functions in innate lymphocyte development by acting as a direct upstream activator of the master NK transcription factor T-BET, defining its first molecular target.\",\n      \"evidence\": \"shRNA silencing, overexpression, and T-BET rescue epistasis in CD34+ cord blood NK differentiation\",\n      \"pmids\": [\"25352127\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding to the TBX21 locus not demonstrated by ChIP\", \"ETS-1 independence shown but other cofactors not mapped\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined TOX2 as a driver of CD8 T cell exhaustion acting combinatorially with TOX and NR4A downstream of NFAT, revealing redundancy within the TOX family in dysfunctional T cells.\",\n      \"evidence\": \"CAR T mouse model, Tox/Tox2 CRISPR double-knockout, ATAC-seq and transcriptional analysis\",\n      \"pmids\": [\"31152140\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct TOX2 target loci in exhaustion not separated from TOX\", \"Mechanism of cooperation with NR4A not biochemically resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed TOX2 is necessary and sufficient for Tfh differentiation through direct genomic binding to Bcl6, identifying the Tox2-Bcl6 feed-forward loop as its core CD4 T cell circuit.\",\n      \"evidence\": \"Tox2-/- mouse, ectopic expression, genome-wide ChIP-seq and ATAC-seq, epistasis with Tox\",\n      \"pmids\": [\"31732165\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactors recruited to TOX2-bound Tfh loci not identified\", \"Relationship to TCM/exhaustion programs in CD8 not addressed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extended the Tfh role to maintenance, showing TOX2 preserves germinal-center Tfh identity and enables memory Tfh generation rather than just initiating differentiation.\",\n      \"evidence\": \"Tox2-/- mouse, overexpression in human GC Tfh cells, reimmunization challenge\",\n      \"pmids\": [\"34623911\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct targets enforcing maintenance versus Th1 conversion not mapped\", \"Memory Tfh persistence mechanism unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Distinguished TOX2 from TOX functionally, demonstrating TOX2 binds TCM gene promoters to promote central-memory differentiation in human CAR T cells, and linked TET2 loss to elevated TOX2.\",\n      \"evidence\": \"TOX2 knockdown, ChIP-seq, ATAC-seq, flow cytometry in human CAR T cells\",\n      \"pmids\": [\"37467321\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab, no in vivo validation\", \"Mechanism reconciling memory-promoting versus exhaustion roles unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified TOX2 as an oncogenic node in NK/T-cell lymphoma driven by RUNX3 via super-enhancer activation, with PRL-3 as a downstream effector.\",\n      \"evidence\": \"shRNA knockdown, CRISPR-dCas9 super-enhancer interference, luciferase reporter, ChIP-PCR, xenograft\",\n      \"pmids\": [\"37032358\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct TOX2 binding to the PRL-3 locus not shown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealed a metabolic function for TOX2 in maintaining gut ILC3 tissue residency through Hexokinase-2-dependent glycolysis, extending its role beyond transcriptional lineage specification.\",\n      \"evidence\": \"Tox2-/- mouse, single-cell transcriptomics, ectopic Hexokinase-2 rescue, Citrobacter infection and glycolysis assays\",\n      \"pmids\": [\"38677292\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding to the Hexokinase-2 locus not demonstrated\", \"Upstream hypoxia/IL-17A signaling to TOX2 not mechanistically mapped\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Uncovered post-translational control of TOX2 via Sirt1/TBK1-regulated deacetylation and translocation, and a TOX2-TOX-LCOR-HDAC3 repressive complex acting on the TIM3 promoter.\",\n      \"evidence\": \"Co-IP, subcellular fractionation, luciferase promoter assay, shRNA, HDAC3 inhibition, xenograft in leukemic cells\",\n      \"pmids\": [\"39080376\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single Co-IP-based complex without reciprocal structural validation\", \"Acetylation sites on TOX2 not mapped\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Provided a genome-wide binding map of TOX2 in primary human CD8 T cells, linking its occupancy to exhaustion and memory gene programs.\",\n      \"evidence\": \"Calling Cards transposon-based TF mapping integrated with multi-omics in primary human CD8 T cells (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.10.09.681414\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single preprint, no functional validation of individual binding events\", \"Direct versus indirect targets not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TOX2 selects between activating (memory, Tfh, T-BET) and repressive (TIM3, exhaustion) transcriptional outputs across lineages, and which cofactors dictate this switch, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified cofactor logic explaining context-dependent activator versus repressor roles\", \"Structural basis of HMG-box target selection not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 2, 5]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 5, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 7]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 2, 5]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 1, 2, 6]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"complexes\": [\"TOX2-TOX-LCOR-HDAC3 repressive complex\"],\n    \"partners\": [\"TOX\", \"LCOR\", \"HDAC3\", \"NR4A\", \"SIRT1\", \"TBK1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}